Avastin Use May Be Overly Restricted By Medicare ESA Proposal – Genentech

CMS' proposal to place limits on erythropoiesis-stimulating agents in the cancer setting might restrict even proper uses of the cancer drug Avastin (bevacizumab), Genentech says